The Ceftazidime for Injection, cataloged under National Stock Number 6505-01-231-9931, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Glaxo Wellcome Inc. Government technical data includes 10 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. 1 item shares a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-231-9931 |
| Primary Part Number | NDC00173-0377-31 |
| Item Name | Ceftazidime for Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Glaxo Wellcome Inc |
| Status | ACTIVE |
| Therapeutic Equivalent | ANY A RATED DRUG |
| Administration | INTRAMUSCULAR OR INTRAVENOUS |
| Primary Container Content Quantity | 500.000 GRAMS G |
| Supplementary Features | MEDSEP ITEM FOR DOD,GLAXO INC |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Features Provided | STERILE |
| Primary Container Type | VIAL |
| Physical Form | POWDER |
| Active Medicament Medicinal Strength | 500.000 GRAMS CEFTAZIDIME, ANHYDROUS EQUIVALENT G |
| Total Primary Container Quantity | 25 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00173-0377-31 PRIMARY | Glaxo Wellcome Inc (USA) |
| Reference | Meaning |
|---|---|
| FORTAZ | 5/1 Secondary reference Glaxo Wellcome Inc |
NSN 6505-01-231-9931 is a Ceftazidime for Injection, manufactured by Glaxo Wellcome Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-231-9931 has 1 manufacturer part number on file: NDC00173-0377-31 (Glaxo Wellcome Inc).
1 possible match (shared part number, not a government interchangeability claim): 6505-01-318-7405. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00173-0377-31: Therapeutic Equivalent: ANY A RATED DRUG; Administration: INTRAMUSCULAR OR INTRAVENOUS; Primary Container Content Quantity: 500.000 GRAMS G; Supplementary Features: MEDSEP ITEM FOR DOD,GLAXO INC. 10 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.